Pembrolizumab
Pembrolizumab
Latest Posts
-
Research study shows merits of using Pembrolizumab as first line treatment of patients with advanced non-small-cell lung cancer and high PD-L1 expression
Pembrolizumab is set to become a new option for first line treatment of patients with advanced lung cancer and high PD-L1 expression, according to the results of the phase III KEYNOTE-024 trial presented at the ESMO 2016…
-
Chemotherapy and pembrolizumab combination significantly improves outcomes in advanced non-small-cell lung cancer
The addition of PD-1 antibody pembrolizumab to standard first-line chemotherapy for treatment-naïve advanced non-small-cell lung cancer significantly improves response rates and progression-free survival, researchers reported at the ESMO 2016 Congress in Copenhagen today. Pembrolizumab is a class…
You must be logged in to post a comment.